Ruchi Bansal is a Tenure-track Assistant Professor and leading her research group Translational Liver Research at the University of Twente, The Netherlands. She obtained her Bachelor’s and Master’s degree in Biochemistry from Delhi University, India. She obtained her PhD in Jan 2012 from the University of Groningen, The Netherlands. Her PhD project was focused on Drug targeting for the treatment of chronic diseases (liver and cancer). During the last stages of her PhD, she received two prestigious grants Sheila Sherlock research fellowship (from European association for the study of liver diseases, EASL) and The Ruth and Richard Julin’s Foundation Swedish research grant for postdoctoral research (2011-2012) at the Karolinska Institute, Stockholm, Sweden.
Her research project was focused on “Pathogenesis of Hepatitis C virus (HCV)-induced and alcohol-induced liver diseases”. She started as a senior postdoctoral researcher in October 2012 at the Department of Biomaterials Science and Technology at the University of Twente. In 2014, she received a prestigious VENI grant (from NWO, ZonMw) to pursue her research on “Development of novel targeted nano-therapeutics for the treatment of liver diseases”. She has received several awards, honors and research grants.
Ruchi has established her independent research team Translational Liver research focusing on Liver diseases: from pathogenesis to nanotherapeutics. She is also a faculty council member, a young academy board member and listed as one of the Featured scientists. Ruchi aim to translate basic science to clinical advancements by developing emerging diagnostics and targeted therapeutics against liver diseases.